SUMMIT OVERVIEW
The Hawaii Breast Cancer Summit is a five-day meeting comprising eight four-hour sessions with presentations by over 60 key opinion leaders. This summit assembles translational researchers, clinical researchers, and key community oncologists to address and discuss challenges in the rapidly developing area of breast cancer and the evolution of treatment approaches.
Featuring didactic lectures, panel discussions, and case presentations highlighting individual patient challenges and new approaches designed to overcome these challenges, the summit reviews compelling data on the effects of novel strategies. Presentations will be given by leading experts in the field of breast cancer who will offer further insight during question-and-answer sessions.
ER+ BREAST CANCER • HER2+ BREAST CANCER • TRIPLE NEGATIVE BREAST CANCER • ANTIBODY DUG CONJUGATES • CDK INHIBITORS • ER DEGRADERS/MODULATORS • PI3K/ AKT INHIBITORS • PI3K/AKT INHIBITORS
DAVA Oncology, PMB Box # 108, 5930 Royal Ln, Ste E, Dallas, TX 75230
Copyright © 2027 Dava Oncology. All rights reserved.